Strumento inattivo

Altre lingue CannPal Animal Therapeutics Limited

Azioni

CP1

AU000000CP17

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Layton Mills and Margaret Curtis agreed to acquire 52% stake in CannPal Animal Therapeutics Limited from AusCann Group Holdings Ltd for AUD1.	10/03/23
AusCann Group Holdings Ltd completed the acquisition of CannPal Animal Therapeutics Limited from Merchant Opportunities Fund, managed by Merchant Funds Management Pty Ltd and others.	11/03/21
Cannpal Animal Therapeutics : Narrows Fiscal H1 Loss on Higher Revenue	19/02/21
Cannpal Animal Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2020	18/02/21
AusCann : CannPal Managing Director to Lead Merged Company Formed With AusCann; CannPal Rises 11%	08/01/21
AusCann Group Holdings Ltd (ASX:AC8) and CannPal Enter Into Scheme of Arrangement	16/11/20
AusCann Group Holdings Ltd entered into a scheme implementation deed to acquire CannPal Animal Therapeutics Limited from Merchant Opportunities Fund, managed by Merchant Funds Management Pty Ltd and others for AUD 16.9 million.	16/11/20
CannPal Animal Therapeutics Limited Announces Resignation of Max Johnston as Non-Executive Director	28/08/20
CannPal Animal Therapeutics : CBD Substantially Improves Atopic Dermatitis Symptoms in Dogs	21/07/20
CannPal Animal Therapeutics Limited Announces Completion of its Safety and Efficacy Study for DermaCann	21/07/20
CannPal Animal Therapeutics Limited Announces FDA Establishes Investigational New Animal Drug file for CPAT-01	10/03/20
Cannpal Animal Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2019	25/02/20
CannPal Animal Therapeutics Limited Enters into Exclusive Licensing Agreement with Commonwealth Scientific and Industrial Research Organisation	05/01/20
49,365,405 Ordinary Shares of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25/10/19
2,000,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25/10/19
625,000 Class A Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25/10/19
1,500,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25/10/19
7,250,000 Options of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25/10/19
625,000 Class B Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25/10/19
625,000 Class C Performance Rights of Cannpal Animal Therapeutics Limited are subject to a Lock-Up Agreement Ending on 25-OCT-2019.	25/10/19

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CannPal Animal Therapeutics Limited

Azioni

CP1

AU000000CP17

Altre lingue

Filtri